Across TCGA pan-cancer cohorts, GPM6BP1 RNA is linked to patient survival in 2 of 34 cancer types, making it the most broadly survival-associated GPM6BP1 data layer.

The strongest signal is observed in glioblastoma multiforme (GBM), where higher GPM6BP1 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated GPM6BP1 expression acts as an unfavorable survival marker.

GBM and LGG are the cancer types where GPM6BP1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
GBM	DFS	Tertile	All	0.081	0.292	.011	27	view →
LGG	DFS	Tertile	All	0.161	0.753	.038	9	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: GPM6BP1 tumor-vs-normal RNA expression · all GPM6BP1 data types